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Despite recent improvements (newer antibiotics, intensive care and surgical 30 
management), left-sided infective endocarditis (IE) is still associated with a significant in-31 
hospital mortality and mid-term attrition rate (1,2). This is particularly true for patients 32 
admitted to intensive care unit (ICU) when endocarditis is due to methicillin-resistant S. 33 
aureus and organ failures occur (3). 34 
Optimal management of IE requires a broad range of expertise (infectious disease 35 
specialists, cardiologists, microbiologists, cardiac surgeons and intensivists). Given the 36 
low level of evidence available for the management of IE, international guidelines are 37 
particularly awaited and rather well implemented (4,5).  38 
This report summarizes newer informations regarding indications and timing of surgery in 39 
the treatment of IE that reflect changes in the epidemiology (new antibiotics, resistant 40 
microorganisms, increased use of cardiovascular implants). They may help select the 41 
best treatment for the patients.  42 
 43 
New evidence from systematic reviews and meta-analyses suggest that surgical 44 
treatment is clearly superior to conservative management. Recently, Narayan published 45 
a meta-analysis on randomized trials, retrospective cohorts and prospective 46 
observational studies comparing outcomes between early surgery (<20 days or less) and 47 
conservative management (6). In summary, early surgery is associated with significantly 48 
lower risk of mortality. Kang compared early surgery to conservative treatment in patients 49 
with IE and large vegetations and found significantly reduced composite end points of 50 
death from any cause and a lower risk of systemic embolism with surgery (7). Moreover, 51 
even in critically ill patients with multiorgan failure, surgery was reasonable in younger 52 
patients (< 60 yrs), in those with predominant cardiac failure and/or with uncontrolled 53 
sepsis (8). 54 
To facilitate decision-making, Wang investigated the utility of risk scores on operative and 55 
long-term mortality. The best tool for post-operative stroke was EuroSCORE II, for 56 
ventilation >24 h the De Feo-Cotrufo Score while pre-operative inotropes, previous 57 
CABG and dialysis were independent predictors of operative and long-term mortality (9).  58 
  59 
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The main message of the ESC guidelines is clear: address patients with IE to an 60 
“Endocarditis Team” in tertiary care centers, facilitate early diagnosis using multimode 61 
imaging and promptly evaluate indications for surgery (10). 62 
 63 
1. Failure to control pulmonary edema or cardiogenic shock or signs of progressive 64 
multiorgan failure within 24 hours of maximal conservative therapy should prompt 65 
evaluation for immediate surgery.  66 
 67 
2. Intracardiac destruction (abscess, severe valve regurgitation, fistula, conduction 68 
disturbances) requires surgery as soon as the complication is diagnosed.  69 
3. Controversy (early versus delayed surgery) exists in following situations:  70 
a. Large or increasing vegetations and at least one embolic episode under adjusted 71 
antibiotic therapy.  72 
 73 
b. IE caused by fungi or multiresistant organisms and specific situations where the risk 74 
of surgery is deemed to be too high. Early surgery may need to be reconsidered due 75 
to the availability of modern bactericidal antibiotics (daptomycin, ceftaroline and 76 
ceftabiprole and fungicidal substances like echinocandins) that may allow successful 77 
medical treatment or widen the window of the optimal timing for surgery. 78 
 79 
c. Stroke:  80 
Mihos published a review on 14 studies that compared early versus delayed surgery for 81 
IE complicated by ischemic stroke (11). Early surgery meant operation performed 3 to 14 82 
days following stroke. Risk ratios were calculated for the outcomes of perioperative 83 
stroke, operative mortality and 1-year survival. Early surgery was associated with a 84 
significantly increased risk of operative mortality - regardless of surgery within the first 7 85 
days after stroke - but with no observed benefit in 1-year survival.  86 
In our institution, we adopt the following strategy : 87 
 88 
a) silent embolism (small MRI finding) or transient ischaemic attack: surgery is performed 89 
without delay, especially in case of haemodynamic deterioration and intracardiac 90 
destruction.  91 
 92 
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b) haemorrhagic transformation of the ischemic lesion: surgery is usually postponed 93 
for 3-4 weeks to avoid full heparinization for the extracorporeal circulation. 94 
Exceptionally, surgery is considered in cases of life-threatening cardiac and/or 95 
hemodynamic condition. A recent report confirmed that early surgery is safe in IE 96 
patients with cerebral infarction, while surgery within 7 days should be avoided in 97 
patients with intracranial hemorrhage (12). 98 
 99 
d) Infection of cardiac devices 100 
The current incidence of ICD infection is unknown but more complex devices and 101 
procedures increase infection rates. Staphylococci cause the majority of infection. All-102 
cause mortality ranges between 0% and 35%. Failure to remove an infected device is 103 
associated with relapse and mortality. Complete and early (as soon as possible, but not 104 
more than 2 weeks after diagnosis) removal of an infected ICD system (generator and all 105 
leads) combined with appropriate antimicrobial therapy is the most effective and safe 106 
treatment option. Percutaneous removal is preferred for infected leads, combined with 107 
removal of the generator while surgical removal should be considered for large lead-108 
associated vegetations and when valve surgery is indicated. 109 
 110 
Surgery for IE,should attempt complete removal of the infected tissue and intracardiac 111 
reconstruction, including repair or replacement of the affected valve(s). Homografts are 112 
considered beneficial in root abscess and aorto-ventricular discontinuity.  113 
In a prospective population-based survey, Iung analyzed the adherence to the guidelines 114 
regarding indications for surgery (14). He found that surgery during acute IE was 115 
recommended in almost three out of four patients, but less than 50% of the patients 116 
received surgery.  117 
The best 1-year survival was observed in patients who had an indication for surgery and 118 
were operated on (14). Chu made a similar observation in 1296 prospectively recruited 119 
patients, Surgical treatment was performed in 57% but only in 76% of patients with a 120 
surgical indication (15). Pat ien ts wh o d id  n ot  un der go su r gical  t r eatm en t  wer e 121 
m or e l i kely  to h ave m ed ical  com or b id i t ies such  as cor on ar y  ar ter y  d isease, 122 
p r ev ious hear t  fai l u r e, d iabetes an d  r en al  d isease an d  to h ave in fect ion  123 
caused  by  S. au r eus. In -h osp i tal  an d  6  m on th -m or tal i t y  wer e h igher  am on g 124 
pat ien ts wh o d id  n ot  un der go su r ger y  com par ed  wi th  th ose wh o d id . In 125 
multivariate analysis, sign i f i can t  p r ed ictor s of  n onsu r gical  t r eatm en t  wer e: 126 
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h istor y  of  m oder ate/ sever e l i ver  d isease, st r oke befor e sur gical  decision  127 
an d  S au r eus et iology . Th e m ost  com m on  r eason  for  lack  of  su r ger y  was 128 
h avin g a poor  p r ogn osis r egar d less of  t r eatm en t  (33.7%) l i ke hem ody n am ic 129 
i n stab i l i t y , death  befor e su r ger y , st r oke, an d  sepsis. 130 
In  pat ien ts wi th  an  in d icat ion  for  su r ger y , su r ger y  was foun d  to be 131 
associated  wi th  h igh er  6-m on th  su r v i val  th an  n o su r ger y . Pat ien ts wi th  132 
h igh er  oper at ive r i sk  wh o un der wen t  su r ger y  h ad  su r v ival  sim i lar  to 133 
pat ien ts wi th  lower  oper at ive r isk  t r eated  wi th ou t  su r ger y , wh er eas 134 
pat ien ts wi th  h igh er  oper at ive r isk  wh o d id  n ot  un der go su r ger y  h ad  ver y  135 
l ow su r v ival  (15) . 136 
 137 
In summary, patients with IE requiring ICU present special problems. Defining the optimal 138 
timing of surgery requires a close interdisciplinary communication between all specialists. 139 
Response to initial treatment of hemodynamics and infection, presence and risk of 140 
complications, and subtle changes in organ function should be taken into account to 141 
outweight risk and benefits of early versus delayed surgical treatment.     142 
 143 
 144 
 145 
 146 
 147 
 148 
 149 
 150 
 151 
 152 
 153 
 154 
 155 
 156 
 157 
 158 
  159 
References 160 
1. Kiefer T, Park L, Tribouilloy C, Cortes C, Casillo R, Chu V et al. Association between 161 
valvular surgery and mortality among patients with infective endocarditis complicated by 162 
heart failure. JAMA 2011;306:2239-47 163 
 164 
2. Lalani T, Chu VH, Park LP, Cecchi E, Corey GR, Durante-Mangoni E et al. In-hospital 165 
and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. 166 
JAMA Intern Med 2013;173:1495-1504. 167 
 168 
3. Leroy O, Georges H, Devos P, Bitton S, De Sa N, Dedrie C, et al. Infective 169 
endocarditis requiring ICU admission: epidemiology and prognosis. Ann Intensive Care 170 
2015;5:45. 171 
 172 
4.. Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F et al.  173 
2015 ESC Guidelines for the management.of infective endocarditis. The Task Force for 174 
the Management of Infective Endocarditis of the European Society of Cardiology (ESC). 175 
Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS) and the 176 
European Association for Nuclear Medicine (EANM). Eur Heart J 2015:36: 3075-3123 177 
 178 
5. Baddour LM, Wilson WR, Bayer AS, Fowler WG, Tleyjeh IM, Rybak MJ et al. Infective 179 
Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of 180 
Complications. A Scientific Statement for Healthcare Professionals From the American 181 
Heart Association. Endorsed by the Infectious Diseases Society of America 182 
Circulation. 2015;132:1435-86 183 
6. Anantha Narayan M, Mahfood Haddad T, Kalil AC, Kanmanthareddy A, Suri RM, 184 
Mansour G et al.  Early versus late surgical intervention or medical management for 185 
infective endocarditis: a systematic review and meta-analysis. Heart 2016;102:950-7. 186 
 187 
7. Kang DH, Kim YJ, Kim SH, Sun BJ, Kim DH, Yun SC et al. Early surgery versus 188 
conventional treatment for infective endocarditis. N Engl J Med 2012;366:2466-73. 189 
 190 
8. Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P, et al. ENDOREA 191 
Study Group. Long-term outcomes and cardaic surgery in critically ill patients with 192 
infective endocarditis. Eur Heart J. 2014;35:1195-204. 193 
9. Wang TK, Oh T, Voss J, Gamble G, Kang N, Pemberton J. Comparison of 194 
contemporary risk scores for predicting outcomes after surgery for active infective 195 
endocarditis. Heart Vessels 2015;30:227-34. 196 
10. Habib G, Lancellotti P. The 2015 ESC Guidelines for the management of infective 197 
endocarditis. Take-home message of the full 2015 ESC Guidelines, also endorsed by 198 
the European Association for Cardio-Thoracic Surgery, European Association of Nuclear 199 
Medicine, and European Society of Clinical Microbiology and Infectious Diseases. 200 
European Heart Journal 2015;36:3036-42. 201 
11. Mihos CG, Pineda AM, Santana O. A Meta-Analysis of Early Versus Delayed Surgery 202 
for Valvular Infective Endocarditis Complicated by Embolic Ischemic Stroke. Innovations 203 
(Phila). 2016 Jul 19. [Epub ahead of print]. 204 
12. Okita Y, Minakata K, Yasuno S, Uozumi R, Sato T, Ueshima K, et al. Optimal timing 205 
of surgery for active infective endocarditis with cerebral complications: a Japanese 206 
multicentre study. Eur J Cardiothorac Surg. 2016;50:374-82. 207 
13. Sandoe JA, Barlow G, Chambers JB, Gammage M, Guleri M, Howard P et al. 208 
Guidelines for the diagnosis, prevention and management of implantable cardiac 209 
electronic device infection. Report of a joint Working Party project on behalf of the British 210 
Society for Antimicrobial Chemotherapy (BSAC, host organization), British Heart Rhythm 211 
Society (BHRS), British Cardiovascular Society (BCS), British Heart Valve Society 212 
(BHVS) and British Society for Echocardiography (BSE). J Antimicrob Chemother. 213 
2015;70:325-59. 214 
14. Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V et al. for 215 
the AEPEI Study Group. Cardiac surgery during the acute phase of infective 216 
endocarditis: discrepancies between European Society of Cardiology guidelines and 217 
practices. Eur Heart J. 2016;37:840-8. 218 
15. Chu VH, Park LP, Athan E, Delahaye F, Freiberger T, Lamas C, et. al. Association 219 
between surgical indications, operative risk and clinical outcome in infective endocarditis: 220 
a prospective study from the International  Collaboration on Endocarditis. Circulation. 221 
2015;131:131-40.  222 
Table 223 
Most important informations regarding indications and timing of surgery in left-sided 224 
native and prosthetic valve endocarditis (from ESC Guidelines, 2015 - reference 4) 225 
 226 
Immediate  Emergency surgery must be performed irrespective of the status of  227 
(same day)  infection, when patients are in persistent pulmonary oedema or   228 
cardiogenic shock despite medical therapy. 229 
 230 
    Urgent - Severe valvular regurgitation or obstruction leading to heart failure 231 
(within days)              - Poor haemodynamic tolerance (high end-diastolic LV-pressure,     232 
  moderate to severe pulmonary artery hypertension). 233 
- Uncontrolled infection leading to intracardiac destruction.  234 
- Increasing vegetation despite adequate antibiotic treatment. 235 
- Persistent vegetations > 10 mm after more than one embolic episode   236 
- Endocarditis caused by fungi or multiresistant organisms (relative     237 
  indication). 238 
 239 
   Delayed - Surgery should be considered depending on the tolerance of the  240 
(within weeks)    valve lesion and according to the recommendations for the treatment         241 
                                     of valve disease. 242 
 243 
Neurological   - no delay following a silent embolism or transient ischaemic attack 244 
complications   if indicated because haemodynamic conditions or intracardiac 245 
   destruction 246 
- interval of 3-4 weeks in case of haemorrhagic transformation of    247 
  ischemic lesions 248 
- no evidence of beneficial effect of angiographic coiling in case of     249 
  unruptured septic cerebral pseudoaneurysms 250 
 251 
 252 
 253 
